{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:20:51Z","timestamp":1787808051063,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268200548198C"],"award-info":[{"award-number":["HHSN268200548198C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UL1 TR002243"],"award-info":[{"award-number":["UL1 TR002243"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.healun.2021.08.015","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T02:55:46Z","timestamp":1631156146000},"page":"1605-1613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impact of renin-angiotensin-aldosterone system inhibition on morbidity and mortality during long-term continuous-flow left ventricular assist device support: An IMACS report"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9511-7767","authenticated-orcid":false,"suffix":"Jr","given":"D. Marshall","family":"Brinkley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4287-334X","authenticated-orcid":false,"given":"E. Wilson","family":"Grandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.08.015_bib0001","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.08.015_bib0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.healun.2018.11.013","article-title":"The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships","volume":"38","author":"Kormos","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.015_bib0003","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.healun.2019.02.004","article-title":"Third annual report from the ISHLT Mechanically Assisted Circulatory Support Registry: a comparison of centrifugal and axial continuous-flow left ventricular assist devices","volume":"38","author":"Goldstein","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.015_bib0004","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cardfail.2016.02.004","article-title":"Use of heart failure medical therapies among patients with left ventricular assist devices: insights from INTERMACS","volume":"22","author":"Khazanie","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2021.08.015_bib0005","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.amjcard.2016.03.011","article-title":"Effect of neurohormonal blockade drug therapy on outcomes and left ventricular function and structure after left ventricular assist device implantation","volume":"117","author":"Grupper","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2021.08.015_bib0006","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2016.06.011","article-title":"Heart failure medications prescribed at discharge for patients with left ventricular assist devices","volume":"179","author":"Shreibati","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2021.08.015_bib0007","article-title":"Longitudinal heart failure medication use and adherence following left ventricular assist device implantation in privately insured patients","volume":"6","author":"Tan Nicholas","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2021.08.015_bib0008","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.healun.2021.08.015_bib0009","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Group TCTS: effects of enalapril on mortality in severe congestive heart failure","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0011","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0012","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0013","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2021.08.015_bib0014","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2019.4965","article-title":"Neurohormonal blockade and clinical outcomes in patients with heart failure supported by left ventricular assist devices","volume":"5","author":"McCullough","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.healun.2021.08.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2018.01.342","article-title":"Outcome and primary endpoint results from a prospective multi-center study of myocardial recovery using LVADs: remission from stage D heart failure (RESTAGE-HF)","volume":"37","author":"Birks","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.015_bib0018","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.08.015_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.109.933960","article-title":"Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy","volume":"123","author":"Birks Emma","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.08.015_bib0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ejhf.1018","article-title":"Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support","volume":"20","author":"Catino","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2021.08.015_bib0021","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1161\/CIRCULATIONAHA.111.084640","article-title":"Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices","volume":"126","author":"Dandel","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.08.015_bib0022","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jacc.2013.01.072","article-title":"Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery","volume":"61","author":"Drakos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2021.08.015_bib0023","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2012.11.019","article-title":"Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study","volume":"32","author":"Patel","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.015_bib0024","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ehf2.12629","article-title":"Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study","volume":"7","author":"Antonides","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2021.08.015_bib0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/eurheartj\/ehp012","article-title":"The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin\u2013angiotensin\u2013aldosterone system: therapeutic consequences?","volume":"30","author":"Klotz","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2021.08.015_bib0026","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2006.10.071","article-title":"The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure","volume":"49","author":"Klotz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2021.08.015_bib0027","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.104.515106","article-title":"Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness","volume":"112","author":"Klotz","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.08.015_bib0028","first-page":"1166","article-title":"Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices","volume":"4","author":"Galand","year":"2018","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.healun.2021.08.015_bib0029","first-page":"818","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg","year":"2015","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.healun.2021.08.015_bib0030","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2019.01.051","article-title":"Effect of angiotensin II inhibitors on gastrointestinal bleeding in patients with left ventricular assist devices","volume":"73","author":"Converse","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2021.08.015_bib0031","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.healun.2016.12.016","article-title":"Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices","volume":"36","author":"Houston","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.015_bib0032","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.healun.2018.12.018","article-title":"Association between angiotensin II antagonism and gastrointestinal bleeding on left ventricular assist device support","volume":"38","author":"Schultz","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.08.015_bib0033","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.94.10.2566","article-title":"New activity of spironolactone","volume":"94","author":"Klauber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.08.015_bib0034","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/01.hjh.0000249698.26983.4e","article-title":"Antiangiogenic effects of spironolactone and other potassium-sparing diuretics in human umbilical vein endothelial cells and in fibrin gel chambers implanted in rats","volume":"24","author":"Miternique-Grosse","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.healun.2021.08.015_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka Jennifer","year":"2009","journal-title":"Circ Res"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821024888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821024888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:41:14Z","timestamp":1760949674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821024888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1053249821024888"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.08.015","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of renin-angiotensin-aldosterone system inhibition on morbidity and mortality during long-term continuous-flow left ventricular assist device support: An IMACS report","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}